#

+1 (917) 893 7512

  • #
  • #
  • #
#
Global Vaccine Market Size & Share | Industry Analysis, 2020

Global Vaccine Market: Size & Forecasts with Impact Analysis of COVID-19 (2020-2024)

Publish Date:Apr 2020
No. of Pages:108

Format : Adobe Reader (PDF) Instant delivery

US$ 1,200.00

Scope of the Report

Best Global Vaccine Market Report from 2020 to 2024

The report titled “Global Vaccine Market: Size & Forecasts with Impact Analysis of COVID-19 (2020-2024)”, provides an in depth analysis of the global vaccine market by value, by disease, by type, by patient type, by region, etc. The report provides a regional analysis of the vaccine market, including the following regions: North America (the US & Rest of North America), Europe, Asia Pacific (China, Japan, India & Rest of Asia Pacific), Latin America and Middle East and Africa. The report also provides a detailed analysis of the COVID-19 impact on the vaccine market.

The report also assesses the key opportunitiesin the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global vaccine market has also been forecasted for the period 2020-2024, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

The global vaccine market is highly dominated with few major market players operating worldwide. The manufacturers of vaccinesproduce different types of vaccines for different diseases and for the patients of different age group. Further, key players of the vaccine market are GlaxoSmithKline plc, Merck & Co., Inc., Sanofi S.A. (Sanofi Pasteur), and Pfizer Inc. are also profiled with their financial information and respective business strategies.

Country Coverage

North America
Europe
Asia Pacific
Latin America
Middle East and Africa

Company Coverage

GlaxoSmithKline plc
Merck & Co., Inc.
Sanofi S.A. (Sanofi Pasteur)
Pfizer Inc.

Executive Summary

Vaccines are substances that inject a weakened form of disease into a person’s body, to stimulate the production of antibodies and to provide immunity against the infectious diseases. While drugs are administered to patients to treat medical problems, vaccines are administered to healthy children or adults to prevent infectious diseases. Vaccines can be injected through a needle; taken by mouth; and inhaled through the nose. Vaccine is considered to be very important, as it protects children from serious complications of preventable diseases. Vaccine is also safe and effective, as it is carefully reviewed by the scientists, doctors and researchers in different phases and trials. Vaccine is also proved beneficial in protecting future generations, because it reduced or may have eliminated the impact of many diseases that killed people just a few generations ago.

There are four main types of vaccines: Live-attenuated vaccines, Inactivated Vaccines, Recombinant/Conjugate/Subunit Vaccines, and Toxoid Vaccines. Vaccines have a long history with continuously evolving premium and new generation vaccines. The vaccine market can be segmented on the basis of disease, type, route of administration, patient type, and end-users.

The global vaccine market has increased at a significant CAGR during the years 2015-2019 and projections are made that the market would rise in the next four years i.e. 2020-2024 tremendously. The vaccine market is expected to increase due to increasing prevalence of infectious diseases, rising focus on immunization, growing population, escalating healthcare spending, surge in the use of adjuvants, rising initiatives by the government and non-government organizations, etc. Yet the market faces some challenges such as inadequate access to vaccines, stringent regulations, etc.


Tags :









1. Executive Summary

2. Introduction

2.1 Vaccine: An Overview 
2.1.1 Importance of Vaccine
2.1.2 History of Vaccine
2.1.3 Types of Vaccines

2.2 Vaccine Segmentation: An Overview
2.2.1 Vaccine Segmentation by Disease
2.2.2 Vaccine Segmentation by Type and Route of Administration
2.2.3 Vaccine Segmentation by Patient Type and End-users

3. Global Market Analysis

3.1 Global Vaccine Market: An Analysis

3.1.1 Global Vaccine Market by Value
3.1.2 Global Vaccine Market by Disease (Streptococcus Pneumonia, Diphtheria, Tetanus and Pertussis (DTP), Influenza, Cancer, Human Papillomavirus (HPV), Neisseria Meningitides, Measles, Mumps, and Rubella (MMR), Hepatitis, Rotavirus, Varicella, and Others)
3.1.3 Global Vaccine Market by Type (Recombinant/Conjugate/Subunit vaccine, Inactivated vaccine, Live-attenuated vaccine, and Toxoid vaccine)
3.1.4 Global Vaccine Market by Patient Type (Pediatric Patients and Adult Patients)
3.1.5 Global Vaccine Market by Region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa)

3.2 Global Vaccine Market: Disease Analysis

3.2.1 Global Streptococcus Pneumonia Vaccine Market by Value 
3.2.2 Global Diphtheria, Tetanus and Pertussis (DTP) Vaccine Market by Value 
3.2.3 Global Influenza Vaccine Market by Value 
3.2.4 Global Cancer Vaccine Market by Value 
3.2.5 Global Human Papillomavirus (HPV) Vaccine Market by Value 
3.2.6 Global Neisseria Meningitides Vaccine Market by Value 
3.2.7 Global Measles, Mumps, and Rubella (MMR) Vaccine Market by Value 
3.2.8 Global Hepatitis Vaccine Market by Value 
3.2.9 Global Rotavirus Vaccine Market by Value 
3.2.10 Global Varicella Vaccine Market by Value 
3.2.11 Global Other Vaccine Market by Value 

3.3 Global Vaccine Market: Type Analysis

3.3.1 Global Recombinant/Conjugate/Subunit Vaccine Market by Value 
3.3.2 Global Inactivated Vaccine Market by Value 
3.3.3 Global Live-attenuated Vaccine Market by Value 
3.3.4 Global Toxoid Vaccine Market by Value 

3.4 Global Vaccine Market: Patient Type Analysis

3.4.1 Global Pediatric Patients Vaccine Market by Value 
3.4.2 Global Adult Patients Vaccine Market by Value 

4. Regional Market Analysis

4.1 North America Vaccine Market: An Analysis

4.1.1 North America Vaccine Market by Value 
4.1.2 North America Vaccine Market by Region (The US and Rest of North America)
4.1.3 The US Vaccine Market by Value 
4.1.4 The US Vaccine Market by Patient Type (Pediatric Patients and Adult Patients)
4.1.5 The US Pediatric Patients Vaccine Market by Value 
4.1.6 The US Adult Patients Vaccine Market by Value 
4.1.7 Rest of North America Vaccine Market by Value 

4.2 Europe Vaccine Market: An Analysis
4.2.1 Europe Vaccine Market by Value 

4.3 Asia Pacific Vaccine Market: An Analysis

4.3.1 Asia Pacific Vaccine Market by Value 
4.3.2 Asia Pacific Vaccine Market by Region (Japan, China, India, and Rest of Asia Pacific)
4.3.3 China Vaccine Market by Value 
4.3.4 Japan Vaccine Market by Value 
4.3.5 India Vaccine Market by Value 
4.3.6 Rest of Asia Pacific Vaccine Market by Value 

4.4 Latin America Vaccine Market: An Analysis
4.4.1 Latin America Vaccine Market by Value 

4.5 Middle East and Africa Vaccine Market: An Analysis
4.5.1 Middle East and Africa Vaccine Market by Value 

5. Market Dynamics

5.1 Growth Driver
5.1.1 Increasing Prevalence of Infectious Diseases
5.1.2 Rising Focus on Immunization
5.1.3 Growing Population
5.1.4 Escalating Healthcare Spending
5.1.5 Surge in the Use of Adjuvants
5.1.6 Rising Initiatives by the Government and Non-Government Organizations

5.2 Challenges
5.2.1 Inadequate Access to Vaccines
5.2.2 Stringent Regulations

5.3 Market Trends
5.3.1 Growing Popularity of Next-generation Vaccines
5.3.2 Increasing Demand for Adult Vaccines
5.3.3 Surge in the Use of Therapeutic Vaccines
5.3.4 Impact of COVID-19 Outbreak

6. Competitive Landscape

6.1 Global Vaccine Players by Market Share
6.2 Global Vaccine Market Players by Major Merger & Acquisition (M&A) Deals
6.3 Global Vaccine Market Players by Vaccine Pipelines
6.4 Global Vaccine Market Players by Vaccines in the Pipelines for COVID-19 

7. Company Profiles

7.1 GlaxoSmithKline plc
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy

7.2 Merck & Co., Inc.
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy

7.3 Sanofi S.A. (Sanofi Pasteur) 
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy

7.4 Pfizer Inc. 
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategy
Figure 1: Importance of Vaccine
Figure 2: History of Vaccine
Figure 3: Types of Vaccines
Figure 4: Vaccine Segmentation by Disease
Figure 5: Vaccine Segmentation by Type and Route of Administration
Figure 6: Vaccine Segmentation by Patient Type and End-users
Figure 7: Global Vaccine Market by Value; 2015-2019 (US$ Billion)
Figure 8: Global Vaccine Market by Value; 2020-2024 (US$ Billion)
Figure 9: Global Vaccine Market by Disease; 2019 (Percentage, %)
Figure 10: Global Vaccine Market by Type; 2019 (Percentage, %)
Figure 11: Global Vaccine Market by Patient Type; 2019 (Percentage, %)
Figure 12: Global Vaccine Market by Region; 2019 (Percentage, %)
Figure 13: Global Streptococcus Pneumonia Vaccine Market by Value; 2017-2019 (US$ Billion)
Figure 14: Global Streptococcus Pneumonia Vaccine Market by Value; 2020-2024 (US$ Billion)
Figure 15: Global DTP Vaccine Market by Value; 2017-2019 (US$ Billion)
Figure 16: Global DTP Vaccine Market by Value; 2020-2024 (US$ Billion)
Figure 17: Global Influenza Vaccine Market by Value; 2017-2019 (US$ Billion)
Figure 18: Global Influenza Vaccine Market by Value; 2020-2024 (US$ Billion)
Figure 19: Global Cancer Vaccine Market by Value; 2017-2019 (US$ Billion)
Figure 20: Global Cancer Vaccine Market by Value; 2020-2024 (US$ Billion)
Figure 21: Global HPV Vaccine Market by Value; 2017-2019 (US$ Billion)
Figure 22: Global HPV Vaccine Market by Value; 2020-2024 (US$ Billion)
Figure 23: Global Neisseria Meningitides Vaccine Market by Value; 2017-2019 (US$ Billion)
Figure 24: Global Neisseria Meningitides Vaccine Market by Value; 2020-2024 (US$ Billion)
Figure 25: Global MMR Vaccine Market by Value; 2017-2019 (US$ Billion)
Figure 26: Global MMR Vaccine Market by Value; 2020-2024 (US$ Billion)
Figure 27: Global Hepatitis Vaccine Market by Value; 2017-2019 (US$ Billion)
Figure 28: Global Hepatitis Vaccine Market by Value; 2020-2024 (US$ Billion)
Figure 29: Global Rotavirus Vaccine Market by Value; 2017-2019 (US$ Billion)
Figure 30: Global Rotavirus Vaccine Market by Value; 2020-2024 (US$ Billion)
Figure 31: Global Varicella Vaccine Market by Value; 2017-2019 (US$ Billion)
Figure 32: Global Varicella Vaccine Market by Value; 2020-2024 (US$ Billion)
Figure 33: Global Other Vaccine Market by Value; 2017-2019 (US$ Billion)
Figure 34: Global Other Vaccine Market by Value; 2020-2024 (US$ Billion)
Figure 35: Global Recombinant/Conjugate/Subunit Vaccine Market by Value; 2017-2019 (US$ Billion)
Figure 36: Global Recombinant/Conjugate/Subunit Vaccine Market by Value; 2020-2024 (US$ Billion)
Figure 37: Global Inactivated Vaccine Market by Value; 2017-2019 (US$ Billion)
Figure 38: Global Inactivated Vaccine Market by Value; 2020-2024 (US$ Billion)
Figure 39: Global Live-attenuated Vaccine Market by Value; 2017-2019 (US$ Billion)
Figure 40: Global Live-attenuated Vaccine Market by Value; 2020-2024 (US$ Billion)
Figure 41: Global Toxoid Vaccine Market by Value; 2017-2019 (US$ Billion)
Figure 42: Global Toxoid Vaccine Market by Value; 2020-2024 (US$ Billion)
Figure 43: Global Pediatric Patients Vaccine Market by Value; 2017-2019 (US$ Billion)
Figure 44: Global Pediatric Patients Vaccine Market by Value; 2020-2024 (US$ Billion)
Figure 45: Global Adult Patients Vaccine Market by Value; 2017-2019 (US$ Billion)
Figure 46: Global Adult Patients Vaccine Market by Value; 2020-2024 (US$ Billion)
Figure 47: North America Vaccine Market by Value; 2017-2019 (US$ Billion)
Figure 48: North America Vaccine Market by Value; 2020-2024 (US$ Billion)
Figure 49: North America Vaccine Market by Region; 2019 (Percentage, %)
Figure 50: The US Vaccine Market by Value; 2017-2019 (US$ Billion)
Figure 51: The US Vaccine Market by Value; 2020-2024 (US$ Billion)
Figure 52: The US Vaccine Market by Patient Type; 2019 (Percentage, %)
Figure 53: The US Pediatric Patients Vaccine Market by Value; 2017-2019 (US$ Billion)
Figure 54: The US Pediatric Patients Vaccine Market by Value; 2020-2024 (US$ Billion)
Figure 55: The US Adult Patients Vaccine Market by Value; 2017-2019 (US$ Billion)
Figure 56: The US Adult Patients Vaccine Market by Value; 2020-2024 (US$ Billion)
Figure 57: Rest of North America Vaccine Market by Value; 2017-2019 (US$ Billion)
Figure 58: Rest of North America Vaccine Market by Value; 2020-2024 (US$ Billion)
Figure 59: Europe Vaccine Market by Value; 2017-2019 (US$ Billion)
Figure 60: Europe Vaccine Market by Value; 2020-2024 (US$ Billion)
Figure 61: Asia Pacific Vaccine Market by Value; 2017-2019 (US$ Billion)
Figure 62: Asia Pacific Vaccine Market by Value; 2020-2024 (US$ Billion)
Figure 63: Asia Pacific Vaccine Market by Region; 2019 (Percentage, %)
Figure 64: China Vaccine Market by Value; 2017-2019 (US$ Billion)
Figure 65: China Vaccine Market by Value; 2020-2024 (US$ Billion)
Figure 66: Japan Vaccine Market by Value; 2017-2019 (US$ Billion)
Figure 67: Japan Vaccine Market by Value; 2020-2024 (US$ Billion)
Figure 68: India Vaccine Market by Value; 2017-2019 (US$ Million)
Figure 69: India Vaccine Market by Value; 2020-2024 (US$ Billion)
Figure 70: Rest of Asia Pacific Vaccine Market by Value; 2017-2019 (US$ Billion)
Figure 71: Rest of Asia Pacific Vaccine Market by Value; 2020-2024 (US$ Billion)
Figure 72: Latin America Vaccine Market by Value; 2017-2019 (US$ Billion)
Figure 73: Latin America Vaccine Market by Value; 2020-2024 (US$ Billion)
Figure 74: Middle East and Africa Vaccine Market by Value; 2017-2019 (US$ Billion)
Figure 75: Middle East and Africa Vaccine Market by Value; 2020-2024 (US$ Billion)
Figure 76: The US Estimated Influenza Disease Burden by Season; 2011-2018 (Million)
Figure 77: Global Vaccination Coverage; 2015-2018 (Percentage, %)
Figure 78: Global Population and Urban Population; 2015-2019 (Billion & Percentage, %)
Figure 79: Global Healthcare Spending by Region; 2017-2022 (US$ Billion)
Figure 80: Global Vaccine Adjuvants Market; 2017-2024 (US$ Million)
Figure 81: Vaccine Platform
Figure 82: Development of COVID-19 Vaccine
Figure 83: Global Vaccine Players by Market Share; 2017 & 2024 (Percentage, %)
Figure 84: GlaxoSmithKline Turnover; 2015-2019 (US$ Billion)
Figure 85: GlaxoSmithKline Turnover by Segments; 2019 (Percentage, %)
Figure 86: GlaxoSmithKline Turnover by Region; 2019 (Percentage, %)
Figure 87: Merck & Co., Inc. Sales; 2015-2019 (US$ Billion)
Figure 88: Merck & Co., Inc. Sales by Segments; 2019 (Percentage, %)
Figure 89: Merck & Co., Inc. Sales by Region; 2019 (Percentage, %)
Figure 90: Sanofi S.A. Net Sales; 2015-2019 (US$ Billion)
Figure 91: Sanofi S.A. Net Sales by Segments; 2019 (Percentage, %)
Figure 92: Sanofi S.A. Net Sales by Region; 2019 (Percentage, %)
Figure 93: Pfizer Inc. Revenues; 2015-2019 (US$ Billion)
Figure 94: Pfizer Inc. Revenues by Segments; 2019 (Percentage, %)
Figure 95: Pfizer Inc. Revenues by Region; 2019 (Percentage, %)
Table 1: Global Vaccine Market Players by Major Merger & Acquisition (M&A) Deals
Table 2: Global Vaccine Market Players by Vaccine Pipelines
Table 3 : Global Vaccine Market Players by Vaccines in the Pipelines for COVID-19